🚀 VC round data is live in beta, check it out!
Exosens Valuation Multiples
Discover revenue and EBITDA valuation multiples for Exosens and similar public comparables like EO Technics, TDG Holding, nLight, RORZE and more.
Exosens Overview
About Exosens
Exosens SA is a high-tech company specializing in electro-optical technologies for amplification, detection, and imaging. It offers products such as night vision tubes, ultraviolet cameras, travelling wave tubes, and various detectors for defense, life sciences, nuclear, and industrial sectors. With multiple production sites in Europe and North America. The company’s activities are organized into two main segments: Amplification, which focuses on electron or electromagnetic wave amplification systems mainly used in defense night vision equipment and generates the majority of its revenue, and Detection & Imaging, which provides high value-added components for commercial markets such as nuclear power, research, and industrial applications.
Founded
2021
HQ
Employees
1.8K
Website
Financials (LTM)
EV
$4B
Exosens Financials
Exosens reported last 12-month revenue of $576M and EBITDA of $187M.
In the same LTM period, Exosens generated $430M in gross profit, $187M in EBITDA, and $67M in net income.
Revenue (LTM)
Exosens P&L
In the most recent fiscal year, Exosens reported revenue of $552M and EBITDA of $179M.
Exosens expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $576M | XXX | $552M | XXX | XXX | XXX |
| Gross Profit | $430M | XXX | $262M | XXX | XXX | XXX |
| Gross Margin | 75% | XXX | 47% | XXX | XXX | XXX |
| EBITDA | $187M | XXX | $179M | XXX | XXX | XXX |
| EBITDA Margin | 32% | XXX | 32% | XXX | XXX | XXX |
| EBIT Margin | 26% | XXX | 26% | XXX | XXX | XXX |
| Net Profit | $67M | XXX | $50M | XXX | XXX | XXX |
| Net Margin | 12% | XXX | 9% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Exosens Stock Performance
Exosens has current market cap of $4B, and enterprise value of $4B.
Market Cap Evolution
Exosens' stock price is $77.05.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $4B | -0.9% | XXX | XXX | XXX | $0.99 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialExosens Valuation Multiples
Exosens trades at 6.6x EV/Revenue multiple, and 20.5x EV/EBITDA.
EV / Revenue (LTM)
Exosens Financial Valuation Multiples
As of April 19, 2026, Exosens has market cap of $4B and EV of $4B.
Equity research analysts estimate Exosens' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Exosens has a P/E ratio of 58.6x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV/Revenue | 6.6x | XXX | 6.9x | XXX | XXX | XXX |
| EV/EBITDA | 20.5x | XXX | 21.4x | XXX | XXX | XXX |
| EV/EBIT | 25.4x | XXX | 26.3x | XXX | XXX | XXX |
| EV/Gross Profit | 8.9x | XXX | 14.6x | XXX | XXX | XXX |
| P/E | 58.6x | XXX | 77.9x | XXX | XXX | XXX |
| EV/FCF | 70.8x | XXX | 30.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Exosens Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Exosens Margins & Growth Rates
Exosens' revenue in the last 12 month grew by 14%.
Exosens' revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Exosens' rule of 40 is 73% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Exosens' rule of X is 133% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Exosens Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 14% | XXX | 15% | XXX | XXX | XXX |
| EBITDA Margin | 32% | XXX | 32% | XXX | XXX | XXX |
| EBITDA Growth | 15% | XXX | 15% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 73% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 133% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 30% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Exosens Public Comps
See public comps and valuation multiples for other Computer Hardware and Sensors & Monitoring comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Exosens | XXX | XXX | XXX | XXX | XXX | XXX |
| EO Technics | XXX | XXX | XXX | XXX | XXX | XXX |
| TDG Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| nLight | XXX | XXX | XXX | XXX | XXX | XXX |
| RORZE | XXX | XXX | XXX | XXX | XXX | XXX |
| Wonik IPS | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Exosens M&A Activity
Exosens acquired XXX companies to date.
Last acquisition by Exosens was on XXXXXXXX, XXXXX. Exosens acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Exosens
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialExosens Investment Activity
Exosens invested in XXX companies to date.
Exosens made its latest investment on XXXXXXXX, XXXXX. Exosens invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Exosens
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Exosens
| When was Exosens founded? | Exosens was founded in 2021. |
| Where is Exosens headquartered? | Exosens is headquartered in France. |
| How many employees does Exosens have? | As of today, Exosens has over 1K employees. |
| Who is the CEO of Exosens? | Exosens' CEO is Jerome Cerisier. |
| Is Exosens publicly listed? | Yes, Exosens is a public company listed on Euronext Paris. |
| What is the stock symbol of Exosens? | Exosens trades under EXENS ticker. |
| When did Exosens go public? | Exosens went public in 2024. |
| Who are competitors of Exosens? | Exosens main competitors are EO Technics, TDG Holding, nLight, RORZE. |
| What is the current market cap of Exosens? | Exosens' current market cap is $4B. |
| What is the current revenue of Exosens? | Exosens' last 12 months revenue is $576M. |
| What is the current revenue growth of Exosens? | Exosens revenue growth (NTM/LTM) is 14%. |
| What is the current EV/Revenue multiple of Exosens? | Current revenue multiple of Exosens is 6.6x. |
| Is Exosens profitable? | Yes, Exosens is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Exosens? | Exosens' last 12 months EBITDA is $187M. |
| What is Exosens' EBITDA margin? | Exosens' last 12 months EBITDA margin is 32%. |
| What is the current EV/EBITDA multiple of Exosens? | Current EBITDA multiple of Exosens is 20.5x. |
| What is the current FCF of Exosens? | Exosens' last 12 months FCF is $54M. |
| What is Exosens' FCF margin? | Exosens' last 12 months FCF margin is 9%. |
| What is the current EV/FCF multiple of Exosens? | Current FCF multiple of Exosens is 70.8x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.